Larger tumor sizes in high-grade MCTs may be related to the greater infiltration of T cells into the tumor and higher IFN-γ expression, and, since high-grade MCTs express PD-L1, checkpoint inhibitor treatments might promote a better response with the modulation of IFN-γ. The gene discussed is IFNG; the disease is neoplasm.